Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,843 | -8,243 | -4,401 | -1,993 | -16,984 |
| Depreciation Amortization | 155 | 106 | 60 | 14 | 0 |
| Accounts payable and accrued liabilities | 132 | 303 | 155 | 43 | N/A |
| Other Working Capital | -357 | -190 | -69 | -386 | 444 |
| Other Operating Activity | 30,424 | 473 | 282 | 237 | 12,025 |
| Operating Cash Flow | $-13,489 | $-7,551 | $-3,973 | $-2,085 | $-4,515 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -92 | -93 | -93 | -88 | 0 |
| Investing Cash Flow | $-92 | $-93 | $-93 | $-88 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 29,977 | 0 | 0 | 0 | 30,905 |
| Financing Cash Flow | $29,977 | $N/A | $0 | $N/A | $30,905 |
| Beginning Cash Position | 27,332 | 27,332 | 27,332 | 27,332 | 942 |
| End Cash Position | 43,728 | 19,688 | 23,266 | 25,159 | 27,332 |
| Net Cash Flow | $16,396 | $-7,644 | $-4,066 | $-2,173 | $26,390 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,489 | -7,551 | -3,973 | -2,085 | -4,515 |
| Capital Expenditure | -92 | -93 | -93 | -88 | N/A |
| Free Cash Flow | -13,581 | -7,644 | -4,066 | -2,173 | -4,515 |